BCRX BIOCRYST PHARMACEUTICALS INC
Price Chart
Executive Summary
Two BioCryst insiders sold a total of $697K in open-market sales within a week of Q1 2026 earnings. The CLO exercised 62,500 options at $5.04 and immediately sold the shares at $9.54 for a $596K profit; a director sold 11,180 shares for $100K. The cluster value is ~0.03% of the $2.3B market cap, well below the 0.1% materiality threshold, and the CLO's sale is a routine cashless exercise pattern. The earnings filing showed in-line ORLADEYO revenue and maintained guidance, providing no bearish catalyst.
Key Financial Metrics
Actionable Insight
The insider sales are routine and immaterial in size. The CLO's sale is a standard cashless exercise pattern, and the director's sale is small. No bearish signal from this cluster. Monitor for any material insider purchases or changes to ORLADEYO prescription trends in the next quarterly update.
Key Facts
- Chief Legal Officer Barnes exercised 62,500 options at $5.04 and sold the shares at $9.54 for $596K on 2026-05-13
- Director McKee sold 11,180 shares at $8.97 for $100K on 2026-05-18
- Total insider sales of $697K represent ~0.03% of BCRX's $2.3B market cap
- Q1 2026 ORLADEYO revenue of $148.3M (+11% YoY) was in line with maintained FY2026 guidance of $625-645M
- Non-GAAP operating profit of $54.2M; GAAP net loss of $721.8M driven by non-cash Astria acquisition charge
- No open-market purchases in the cluster; all sales are either cashless option exercises or small director sales
Financial Impact
Insider sales of $697K are trivial relative to $2.3B market cap (0.03%)
Risk Factors
- No bearish risk from this cluster; sales are too small to signal adverse information
- Q1 GAAP net loss of $721.8M is non-cash and not operationally concerning
- Navenibart Phase 3 enrollment completion by June 2026 is a key catalyst to watch
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BCRX-1779221310869 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
21d ago
|
Insider Cluster
| $8.74 $9.12 | ▲ +4.35% | ▲ +3.11% | $8.43 (−3.55%) |
|
May 13, 2026
27d ago
|
144
| $9.60 $8.74 | ▼ −8.96% | ▼ −8.82% | $8.43 (−12.19%) |
|
May 6, 2026
4w ago
|
8-K
| $8.83 $8.80 | ▼ −0.34% | ▼ −1.47% | $8.43 (−4.53%) |
|
May 4, 2026
5w ago
|
8-K
| $9.20 $8.58 | ▼ −6.74% | ▼ −9.68% | $8.43 (−8.37%) |
|
Apr 23, 2026
6w ago
|
DEFA14A
| $8.94 $9.16 | ▲ +2.46% | ▲ +1.55% | $8.43 (−5.70%) |
|
Apr 15, 2026
7w ago
|
Press Release
| $9.44 $9.01 | ▼ −4.56% | ▼ −6.19% | $8.43 (−10.70%) |
|
Mar 16, 2026
12w ago
|
Insider Cluster
| $9.30 $9.80 | ▲ +5.38% | ▲ +7.42% | $8.43 (−9.35%) |
|
Feb 26, 2026
14w ago
|
8-K
| $7.90 $8.50 | ▲ +7.59% | ▲ +8.72% | $8.43 (+6.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access